Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
ClearPoint Neuro, Inc. stock logo
CLPT
ClearPoint Neuro
$13.44
-2.9%
$11.50
$8.27
$30.10
$415.06M1.31553,469 shs448,348 shs
Delcath Systems, Inc. stock logo
DCTH
Delcath Systems
$11.72
-0.4%
$10.78
$8.12
$15.57
$406.15M0.54530,103 shs299,613 shs
Fonar Corporation stock logo
FONR
Fonar
$19.09
$18.88
$13.62
$19.16
$117.84M0.95140,673 shsN/A
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
$17.82
-0.1%
$17.12
$14.42
$23.70
$457.96M1.03116,609 shs96,185 shs
7 Stocks to Buy Before the Robotics Revolution Cover

Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries.

"Physical AI" is coming to the United States, and there are four ways that investors can gain exposure to this new robotics revolution. Plus, learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
ClearPoint Neuro, Inc. stock logo
CLPT
ClearPoint Neuro
+0.65%-3.35%+9.49%+28.27%+7.70%
Delcath Systems, Inc. stock logo
DCTH
Delcath Systems
+5.18%+9.08%+3.79%+24.55%-26.25%
Fonar Corporation stock logo
FONR
Fonar
0.00%0.00%+1.22%+3.86%+31.56%
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
-3.41%-1.49%+0.62%+3.00%-19.32%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
ClearPoint Neuro, Inc. stock logo
CLPT
ClearPoint Neuro
$13.44
-2.9%
$11.50
$8.27
$30.10
$415.06M1.31553,469 shs448,348 shs
Delcath Systems, Inc. stock logo
DCTH
Delcath Systems
$11.72
-0.4%
$10.78
$8.12
$15.57
$406.15M0.54530,103 shs299,613 shs
Fonar Corporation stock logo
FONR
Fonar
$19.09
$18.88
$13.62
$19.16
$117.84M0.95140,673 shsN/A
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
$17.82
-0.1%
$17.12
$14.42
$23.70
$457.96M1.03116,609 shs96,185 shs
7 Stocks to Buy Before the Robotics Revolution Cover

Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries.

"Physical AI" is coming to the United States, and there are four ways that investors can gain exposure to this new robotics revolution. Plus, learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
ClearPoint Neuro, Inc. stock logo
CLPT
ClearPoint Neuro
+0.65%-3.35%+9.49%+28.27%+7.70%
Delcath Systems, Inc. stock logo
DCTH
Delcath Systems
+5.18%+9.08%+3.79%+24.55%-26.25%
Fonar Corporation stock logo
FONR
Fonar
0.00%0.00%+1.22%+3.86%+31.56%
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
-3.41%-1.49%+0.62%+3.00%-19.32%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
ClearPoint Neuro, Inc. stock logo
CLPT
ClearPoint Neuro
2.33
Hold$18.0033.93% Upside
Delcath Systems, Inc. stock logo
DCTH
Delcath Systems
2.43
Hold$22.5091.98% Upside
Fonar Corporation stock logo
FONR
Fonar
2.00
HoldN/AN/A
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
2.82
Moderate Buy$24.4437.17% Upside

Current Analyst Ratings Breakdown

Latest FONR, KIDS, CLPT, and DCTH Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
6/9/2026
ClearPoint Neuro, Inc. stock logo
CLPT
ClearPoint Neuro
Set Price Target$16.00
5/11/2026
Delcath Systems, Inc. stock logo
DCTH
Delcath Systems
UpgradeSell (D)Sell (D+)
5/11/2026
Delcath Systems, Inc. stock logo
DCTH
Delcath Systems
DowngradeHoldStrong Sell
5/8/2026
ClearPoint Neuro, Inc. stock logo
CLPT
ClearPoint Neuro
Initiated CoverageBuy$16.00
5/1/2026
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
Set Price Target$17.00
5/1/2026
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
Reiterated RatingBuy$24.00
4/24/2026
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
Set Price Target$25.00
4/21/2026
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
Reiterated RatingSell (E+)
4/20/2026
ClearPoint Neuro, Inc. stock logo
CLPT
ClearPoint Neuro
Reiterated RatingSell (D-)
4/7/2026
Fonar Corporation stock logo
FONR
Fonar
Reiterated RatingHold (C)
3/18/2026
ClearPoint Neuro, Inc. stock logo
CLPT
ClearPoint Neuro
Boost Price TargetBuy$18.00 ➝ $20.00
(Data available from 6/12/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
ClearPoint Neuro, Inc. stock logo
CLPT
ClearPoint Neuro
$36.97M10.90N/AN/A$0.99 per share13.58
Delcath Systems, Inc. stock logo
DCTH
Delcath Systems
$85.23M4.75$0.05 per share214.06$3.15 per share3.72
Fonar Corporation stock logo
FONR
Fonar
$105.34M1.12$2.10 per share9.09$25.81 per share0.74
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
$236.35M1.94$0.16 per share111.01$13.82 per share1.29
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
ClearPoint Neuro, Inc. stock logo
CLPT
ClearPoint Neuro
-$25.54M-$1.01N/AN/AN/A-71.57%-140.96%-36.98%8/11/2026 (Estimated)
Delcath Systems, Inc. stock logo
DCTH
Delcath Systems
$2.70M$0.011,172.00N/AN/A0.62%0.51%0.46%8/5/2026 (Estimated)
Fonar Corporation stock logo
FONR
Fonar
$8.33M$1.0019.09N/AN/A6.35%4.12%3.07%N/A
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
-$39.65M-$1.68N/AN/AN/A-16.31%-7.01%-4.86%8/4/2026 (Estimated)

Latest FONR, KIDS, CLPT, and DCTH Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/13/2026Q1 2026
ClearPoint Neuro, Inc. stock logo
CLPT
ClearPoint Neuro
-$0.28-$0.32-$0.04-$0.32$11.97 million$12.13 million
5/11/2026Q3 2026
Fonar Corporation stock logo
FONR
Fonar
N/A$0.24N/A$0.24N/A$26.47 million
5/7/2026Q1 2026
Delcath Systems, Inc. stock logo
DCTH
Delcath Systems
-$0.0971-$0.03+$0.0671-$0.03$23.51 million$24.99 million
4/30/2026Q1 2026
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
-$0.4552-$0.42+$0.0352-$0.45$58.29 million$59.36 million
3/17/2026Q4 2025
ClearPoint Neuro, Inc. stock logo
CLPT
ClearPoint Neuro
-$0.22-$0.27-$0.05-$0.27$10.40 million$10.41 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
ClearPoint Neuro, Inc. stock logo
CLPT
ClearPoint Neuro
N/AN/AN/AN/AN/A
Delcath Systems, Inc. stock logo
DCTH
Delcath Systems
N/AN/AN/AN/AN/A
Fonar Corporation stock logo
FONR
Fonar
N/AN/AN/AN/AN/A
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
ClearPoint Neuro, Inc. stock logo
CLPT
ClearPoint Neuro
2.63
5.79
4.88
Delcath Systems, Inc. stock logo
DCTH
Delcath Systems
N/A
11.24
10.33
Fonar Corporation stock logo
FONR
Fonar
N/A
9.18
9.00
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
0.29
5.21
2.37

Institutional Ownership

CompanyInstitutional Ownership
ClearPoint Neuro, Inc. stock logo
CLPT
ClearPoint Neuro
30.08%
Delcath Systems, Inc. stock logo
DCTH
Delcath Systems
61.12%
Fonar Corporation stock logo
FONR
Fonar
50.64%
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
69.05%

Insider Ownership

CompanyInsider Ownership
ClearPoint Neuro, Inc. stock logo
CLPT
ClearPoint Neuro
6.94%
Delcath Systems, Inc. stock logo
DCTH
Delcath Systems
19.36%
Fonar Corporation stock logo
FONR
Fonar
7.93%
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
32.70%
CompanyEmployeesShares OutstandingFree FloatOptionable
ClearPoint Neuro, Inc. stock logo
CLPT
ClearPoint Neuro
11029.99 million27.91 millionOptionable
Delcath Systems, Inc. stock logo
DCTH
Delcath Systems
6034.52 million27.84 millionOptionable
Fonar Corporation stock logo
FONR
Fonar
4806.17 million5.68 millionNot Optionable
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
20025.68 million17.29 millionOptionable

Recent News About These Companies

OrthoPediatrics (KIDS) Q1 2026 Earnings Transcript
OrthoPediatrics Earnings Call Flags Profitable Turn

New MarketBeat Followers Over Time

Media Sentiment Over Time

ClearPoint Neuro stock logo

ClearPoint Neuro NASDAQ:CLPT

$13.44 -0.40 (-2.89%)
Closing price 04:00 PM Eastern
Extended Trading
$13.53 +0.09 (+0.64%)
As of 07:33 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

ClearPoint Neuro, Inc. operates as a medical device company primarily in the United States. It develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under magnetic resonance imaging guided interventions. The company offers ClearPoint system, an integrated system for the insertion of deep brain stimulation electrodes, biopsy needles, and laser catheters, as well as the infusion of pharmaceuticals into the brain. It has license and collaboration agreement with Clinical Laserthermia Systems AB; license and research agreement with Koninklijke Philips N.V., UCB Biopharma SRL, and University of California and San Francisco; and development and license agreement with NE Scientific, LLC. The company was formerly known as MRI Interventions, Inc. and changed its name to ClearPoint Neuro, Inc. in February 2020. ClearPoint Neuro, Inc. was incorporated in 1998 and is headquartered in Solana Beach, California.

Delcath Systems stock logo

Delcath Systems NASDAQ:DCTH

$11.72 -0.05 (-0.42%)
Closing price 04:00 PM Eastern
Extended Trading
$11.77 +0.05 (+0.40%)
As of 07:57 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Delcath Systems, Inc., an interventional oncology company, focuses on the treatment of primary and metastatic liver cancers in the United States and Europe. The company's lead product candidate is HEPZATO KIT, a melphalan for injection/hepatic delivery system to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. Its clinical development program for HEPZATO is the FOCUS clinical trial for patients with metastatic hepatic dominant Uveal Melanoma to investigate objective response rate in metastatic uveal melanoma. It also provides HEPZATO as a stand-alone medical device under the CHEMOSAT Hepatic Delivery System trade name for Melphalan or CHEMOSAT for medical centers to treat a range of liver cancers in Europe. Delcath Systems, Inc. was incorporated in 1988 and is headquartered in New York, New York.

Fonar stock logo

Fonar NASDAQ:FONR

$19.09 0.00 (0.00%)
As of 06/5/2026

FONAR Corporation, together with its subsidiaries, engages in the research, development, production, and marketing of magnetic resonance imaging (MRI) scanners for the detection and diagnosis of human diseases in the United States. The company operates in two segments, Medical Equipment, and Physician Management and Diagnostic Services. It provides Upright MRI scanner that allows patients to be scanned in weight-bearing conditions, such as standing, sitting, bending, or lying down. The company also offers non-medical management, including administrative services, billing and collection services, credentialing services, contract negotiations, compliance consulting, purchasing IT services, hiring, conducting interviews, training, supervision and management of non-medical personnel, storage of medical records, office space, equipment, repair maintenance services, accounting, assistance with compliance matters, and development and implementation of practice growth and marketing strategies. It owns and operates diagnostic imaging facilities in Florida; and manages MRI scanning facilities. The company markets its scanners to private diagnostic imaging centers and hospital outpatient imaging facilities. FONAR Corporation was founded in 1970 and is based in Melville, New York.

OrthoPediatrics stock logo

OrthoPediatrics NASDAQ:KIDS

$17.82 -0.01 (-0.06%)
Closing price 04:00 PM Eastern
Extended Trading
$17.84 +0.02 (+0.11%)
As of 05:35 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products. Its products comprise PediLoc, PediPlates, cannulated screws, PediFlex nail, PediNail, PediLoc Tibia, ACL Reconstruction System, Locking Cannulated Blade, Locking Proximal Femur, Spica Tables, RESPONSE Spine, BandLoc, Pediguard, Pediatric Nailing Platform | Femur, Devise Rail, Orthex, The Fassier-Duval Telescopic Intramedullary System, SLIMTM Nail, The GAP Nail, The Free Gliding SCFE Screw System, GIROTM Growth Modulation System, PNP Tibia System, ApiFix Mid-C System, and Mitchell Ponseti. The company serves pediatric orthopedic market, as well as pediatric orthopedic surgeons and caregivers. OrthoPediatrics Corp. was founded in 2006 and is headquartered in Warsaw, Indiana.